Previous Article | Next Article 
Journal of Virology, April 2000, p. 3874-3880, Vol. 74, No. 8
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Measles Virus-Induced Disruption of the
Glial-Fibrillary-Acidic Protein Cytoskeleton in an Astrocytoma Cell
Line (U-251)
W. Paul
Duprex,1,*
Stephen
McQuaid,2 and
Bert K.
Rima1
School of Biology and Biochemistry, The
Queen's University of Belfast, Belfast BT9
7BL,1 and Neuropathology Laboratory,
Royal Group of Hospitals Trust, Belfast BT12
6Bl,2 Northern Ireland, United Kingdom
Received 20 October 1999/Accepted 9 December 1999
 |
ABSTRACT |
A recombinant measles virus which expresses enhanced green
fluorescent protein (MVeGFP) has been used to infect two astrocytoma cell lines (GCCM and U-251) to study the effect of virus infection on
the cytoskeleton. Indirect immunocytochemistry was used to demonstrate
the cellular localization of the cytoskeletal components. Enhanced
green fluorescent protein autofluorescence was used to identify measles
virus-infected cells. No alteration of the actin, tubulin, or vimentin
components of the cytoskeleton was observed in either cell type,
whereas a disruption of the glial-fibrillary-acidic protein filament
(GFAP) network was noted in MVeGFP-infected U-251 cells. The relative
amounts of GFAP present in infected and uninfected U-251 cells were
quantified by image analysis of data sets obtained by confocal
microscopy by using vimentin, another intermediate filament on which
MVeGFP has no effect, as a control.
 |
TEXT |
The advent of reverse genetics for
negative-stranded RNA viruses provides new opportunities for the
examination and reassessment of various aspects of the virus infection
process. Measles virus (MV) is a Morbillivirus
which belongs to the Paramyxoviridae. Like the other members
of this family, MV has a single-stranded negative-sense RNA genome
which is encapsidated by nucleoprotein (N). Six structural genes are
encoded by the genome. The polymerase (L) and phosphoprotein (P)
associate with the N protein to generate the helical ribonucleocapsid
structure. Two glycoproteins, fusion (F) and hemagglutinin (H), are
embedded in the pleomorphic virion envelope, and these mediate cell
entry and fusion (9, 13, 39, 55). The matrix protein (M)
associates with both the glycoproteins and the ribonucleocapsid
structure and plays a key role in virion assembly (8, 41).
Many viruses have been shown to cause alterations to the cytoskeleton
during in vitro infection (6, 10, 43, 47). For a review, see
the work of Cudmore et al. (12). The Morbillivirus Canine distemper virus (CDV), has been reported to cause a total reorganization of the cytoskeleton, with the most notable alterations being in the microtubule and intermediate-filament networks
(26). Vesicular stomatitis virus (VSV) infection,
first, causes disassembly of the actin filaments and, second, alters
the distribution of the microtubules and intermediate filaments
(44, 47). Respiratory syncytial virus (RSV) also
causes a disruption of the cytoskeleton (7, 21, 52). The
effect of MV on the actin cytoskeleton is less clear. One group has
reported a striking decrease in the overall number of actin bundles in
human fibroblasts infected with MV. They also show a similar disruption
upon infection with other Paramyxoviridae (16,
17). Contrary to this, a second group has not been able to
demonstrate alterations to the actin cytoskeleton in MV-infected Vero
cells (2).
Treatment of MV-infected cells with the actin-depolymerizing agent
cytochalasin B (CB) results in the inhibition of virus maturation. This
suggests that microfilaments play a role in the release of budding
virions (2, 48, 51). Actin filaments have been shown to have
a role in the movement of MV glycoproteins on the surfaces of infected
cells (14). The involvement of actin filaments in the
budding of MV has been examined by electron microscopy (4,
5). Again, a close association exists between actin filaments
from the outer part of the cytoskeletal network and budding virus, with
the filaments protruding into the particles. It has been suggested that
budding is possibly the result of a vectorial growth of actin filaments
(4). CB inhibits the production of infectious virus
particles of other paramyxoviruses (7, 11, 24).
Interestingly, CB has no effect on the maturation of VSV
(23), which has been unequivocally shown to disrupt the actin cytoskeleton (44, 47). Recently the essential role of cellular actin in the gene expression and morphogenesis of RSV has been
described. In this instance RSV infection causes a gross disruption of
the actin cytoskeleton (7). Thus, there appears to be
confusion in the literature. Additionally, it is not clear whether
these alterations are active, i.e., induced to facilitate virus growth,
or passive, i.e., simply caused as a result of infection but playing no
formal role in virus replication.
A number of virus genomes, such as Simian virus 5,
Mouse hepatitis virus, Human herpesvirus, and
Simian varicella-zoster virus, have been engineered to
express green fluorescent protein (GFP) (18, 19, 25b, 32).
Recently the gene encoding enhanced GFP (EGFP) has been introduced into
the MV genome, and a recombinant virus (MVeGFP) has been rescued
(25a). We have demonstrated that EGFP is detectable in cells
in the early stages of infection (13a). In all cases diffuse
EGFP autofluorescence was detectable before viral antigen was detected
by immunocytochemistry. Therefore, EGFP appears to be an ideal
indicator of early MV cell infection and the recombinant virus appears
to be very useful for in vitro studies and may also be beneficial for
in vivo investigations. The diffuse nature of EGFP autofluorescence
makes MVeGFP an ideal candidate for assessing the effects of virus
replication on the cytoskeletons of MVeGFP-infected cells. As tubulin
has been shown to stimulate MV RNA synthesis in vitro (36)
and the fate of actin within MV-infected cells remains unclear (2,
16, 17), we decided to use MVeGFP to investigate the effects of
MV infection on the cytoskeleton. Confocal scanning laser microscopy
(CSLM) was used to gain maximal resolution in dually labeled specimens.
MVeGFP infects astrocytoma cells.
MV infection of the central
nervous system (CNS) is a rare event (27, 30).
Oligodendrocytes and neurons are the predominantly infected cell types,
although infected astrocytes have also been described (1, 30, 31,
34). In this study we have used two astrocytoma cell lines, the
first being GCCM cells, which have been used to study MV cell-to-cell
spread (13a). This cell line was derived from an anaplastic
astrocytoma (grade IV). The second cell line used was U-251 MG cells,
which were established from a human glioma (3). These cells
have been used to examine the induction of inflammatory cytokines upon
MV infection (22, 45). Both cell lines were maintained in
RPMI 1640 medium supplemented with 5% fetal calf serum. MVeGFP virus
was rescued from a full-length antigenomic clone (25a) by
using a cell line which expresses T7 RNA polymerase and the N and P
proteins of MV (42). MVeGFP was propagated in African green
monkey kidney cells (Vero). The gene encoding EGFP is present in an
additional transcription unit (ATU) which is inserted before the N gene
in the MV genome in the most promoter-proximal position. Due to this
location, large amounts of EGFP are produced in infected cells. No
major effects on the replication of the virus and the type of
cell-pathogenic effect generated was observed (25a).
Autofluorescence was readily observed during virus rescue and
propagation by UV microscopy. Cells which showed none of the
well-characterized signs of MV-induced cell-pathogenic effects were
frequently observed. This demonstrates the strength of using MVeGFP for
these experiments in that observations of the cytoskeletons of cells in
the very early stages of virus infection can be made.
MVeGFP has no effect on the actin-, tubulin-, or vimentin-based
cytoskeletons of astrocytoma cells.
GCCM and U-251 cells were
grown to a confluence of 80% on glass coverslips. Cells were infected
with MVeGFP at multiplicity of infection of 0.01 for 1 h at
37°C, after which time the inoculum was removed and maintenance
medium, RPMI 1640 containing 2% fetal calf serum, was added.
Infections were carried out for 50 h at 37°C. During this time
the cells attained 95 to 100% confluence. Cells were permeabilized and
fixed by using freshly prepared 4% paraformaldehyde. The cytoskeletons
of the cells were visualized with a monoclonal antibody specific for
either tubulin (Sigma) or vimentin (Dako). Antivimentin and antitubulin
antibodies were diluted in phosphate-buffered saline (PBS) containing
0.5% Triton X-100 (1:100 and 1/1,500, respectively). The detergent was
included to increase the permeability of the paraformaldehyde-fixed
cells. Antibodies were incubated on the coverslips for 20 h at
4°C. Unbound antibodies were removed by three washes in PBS, each
lasting 5 min. CY3-conjugated sheep anti-mouse immunoglobulin G (Sigma) was used as a secondary antibody. Dilutions (1:40) were made in PBS
containing 0.5% Triton X-100, and the antibody was incubated on the
coverslips for 3 h at 37°C. Unbound antibody was removed as
described above. Tetramethyl rhodamine isothiocyanate
(TRITC)-conjugated phalloidin (Sigma), a fluorescently conjugated
phallotoxin from Amanita phalloides which specifically binds
to F-actin, was used to directly stain the microfilaments.
TRITC-conjugated phalloidin (200 ng/ml) in PBS was incubated on the
coverslips for 2 h at 37°C. Excess phalloidin was removed by a
single PBS wash. Coverslips were mounted with Citifluor (Amersham). A
Leica TCS/NT confocal microscope equipped with a krypton-argon laser as
the source for the ion beam was used to examine the samples for
fluorescence. CY3-stained samples were imaged by excitation at 568 nm
with a 564- to 596-band-pass emission filter. EGFP was visualized by virtue of its autofluorescence by excitation at 488 nm with a 506- to
538-band-pass emission filter. Data sets were collected by dual
excitation, and image stacks were accumulated every 0.5 µm through an
optical plane of 5 µm. Composite images were generated for the
separate EGFP (green) and TRITC (red) channels in single-excitation mode to prevent spillover artifacts. Images were accumulated from regions of the monolayer which contained uninfected and infected cells
and thereby permitted direct comparison of their cytoskeletal networks.
MVeGFP infection of GCCM and U-251 cells led to extensive fusion.
Syncytia which are typical of MV-infected cells were observed. Nuclei
clustered in the centers of the syncytia, and possibly due to a
nonspecific accumulation of EGFP, these were brightly autofluorescent,
as is shown for both cell types in Fig.
1. EGFP was present diffusely throughout the cytoplasm, and no overlap was
observed between the green and red channels. This is particularly important as the most readily detectable MV antigens, N and P, produce
a pronounced punctate staining pattern in extensively fused syncytia.
Under these conditions, any overlap between channels by standard,
dual-labeling indirect immunofluorescence may give the impression that
alterations have occurred in the cytoskeleton. This effect is absent
when MVeGFP infection is used in conjunction with CSLM, and thus this
combined technology provides an excellent approach for examination of
the effects of MV on the cytoskeleton. Using this approach, we
investigated the effects of infection on microtubule,
intermediate-filament, and microfilament components of the
cytoskeletons of U-251 and GCCM cells.


View larger version (8939K):
[in this window]
[in a new window]
|
FIG. 1.
Effect of MVeGFP infection on the cytoskeletons of GCCM
and U-251 astrocytoma cells. Astrocytoma cells were infected with
MVeGFP at a multiplicity of infection of 0.01 for 50 h. Cells were
fixed and examined by CSLM for autofluorescence and immunoreactivity.
Micrographs represent an 8- to 10-µm-deep composite optical section,
and all images were obtained in double-excitation mode. EGFP was
detected by virtue of its autofluorescence (green). (A) Actin
microfilaments in GCCM and U-251 cells were visualized using
TRITC-labeled phalloidin (red). The arrow indicates a single actin
stress fiber in a GCCM cell. The arrowhead indicates a nonfibrillary
aggregation of actin in a U-251 cell. (B) Tubulin was visualized using
a monoclonal antibody and a CY3-conjugated secondary antibody (red).
The arrow indicates a tubulin-rich astrocytic process from a GCCM cell.
The arrowhead in the U-251 panel indicates tubulin accumulation around
the nucleus of an unaffected cell. (C) Vimentin was visualized using a
monoclonal antibody and a CY3-conjugated secondary antibody (red). The
arrowhead indicates an astrocytic process from a U-251 cell.
Magnification, ×400.
|
|
Actin.
No disruption of the actin-based cytoskeleton was
observed upon MVeGFP infection of either cell type (Fig. 1A). Actin is
present in two forms within cells, a globular, monomeric form (G-actin) and a polymerized, filamentous form (F-actin). It is the latter form
which contributes to the cytoskeleton and is detected by phalloidin
(29). The distributions of F-actin in GCCM and U-251 cells
were similar to that observed in a previous study (20). In
uninfected cells F-actin was present in long parallel stress fibers.
These ran along the long axes of the cells. Cortical filaments outlined
the peripheries of both cell types. In MVeGFP-infected cells which
formed syncytia, the microfilaments were integrated into a larger, but
organizationally similar, network. Extended fibers, which were greater
in length than those of the single cells, spanned the syncytia (Fig.
1A, GCCM), indicating that actin polymerization does not seem to be
inhibited by virus infection. Clumping of actin was noted in the U-251
cells (Fig. 1A). Equivalent amounts of F-actin appear to be present in
both uninfected and infected cells. Actin bundles were more prevalent
in MVeGFP-infected GCCM cells (Fig. 1A) than in U-251 cells. These
observations confirm what was previously shown for nonrecombinant
MV-infected Vero cells (2) and contrast with the results of
two studies (16, 17) which observed severe actin disruption
during MV infection of a human lung cell line. We have confirmed that
MVeGFP infection of Vero cells causes no disruption of the actin
cytoskeleton (data not shown). In a recent report, (24)
colocalization of human parainfluenza virus type 3 (HPIV3)
ribonucleoprotein (RNP) and actin microfilaments was observed in
infected CV-1 cells by confocal microscopy with an HPIV3 polyclonal
antiserum. The extent of colocalization was striking and demonstrates
the usefulness of CSLM in this type of investigation. In MV-infected
cells we have never observed a close relationship between MV RNP and
the actin cytoskeleton using either polyclonal or monoclonal antibodies
(anti-P or anti-N antibodies) for staining. This result is in spite of
the fact that actin is known to associate with MV nucleocapsid
(36). Rather, a punctate perinuclear staining pattern in
which antigen is detected in MV-induced cytoplasmic inclusion bodies is
observed. The HPIV3 system appears to be unique in that the actin
microfilaments seem to be directly involved in viral-RNA synthesis in
vivo (24). Interestingly, no disruption of the actin
cytoskeleton was observed upon HPIV3 infection.
Tubulin.
This component of the cytoskeleton has been
implicated as having a role in the MV life cycle, possibly as a subunit
of the viral RNA polymerase (35). The distribution of the
microtubules in MV-infected cells has not been examined previously by
immunocytochemistry. The tubulin-based cytoskeletons are quite similar
in organization in both the GCCM and U-251 cells. The microtubule
bundles are thinner and more filamentous than F-actin stress fibers
which cross syncytia. Generally, tubulin was present throughout the cell at similar levels, although the processes seemed to be
particularly rich in microtubules (Fig. 1B, GCCM). There may be a
slight accumulation of tubulin around the nuclei of the U-251 cells
(Fig. 1B). Tubulin distribution was examined in MVeGFP-infected GCCM
cells. No disruption of the cytoskeleton was observed in infected
cells. Filaments were longer in the syncytia, indicating that the
dynamic process of microtubule assembly is not perturbed in infected
cells engulfed in syncytia. One investigation has reported a thickening
of the microtubules in Hep-2 cells infected with the closely related Morbillivirus CDV (26). Bright foci and thick,
long bundles crossing near or among the multiple nuclei were also
observed in these syncytia. We have not been able to detect any such
accumulation in MV-infected astrocytoma cells. Disruption of the
microtubules has been suggested to have a role in the bipolar budding
of Sendai virus (50). A mutant virus which buds
in a bipolarized manner has alterations in the M protein, and it has
been suggested that this protein may cause the alteration of
microtubules. Involvement of the VSV M protein in microtubule
disruption has also been suggested (47). In that study major
changes in tubulin distribution were detected soon after VSV infection.
As is the case for MV, a role has also been suggested for tubulin in
VSV viral transcription (35).
Vimentin.
The intermediate filament, vimentin, is a major
component of the cytoskeleton. The fate of the vimentin network in
MV-infected cells has not been examined previously. In uninfected GCCM
and U-251 cells the overall structure of the vimentin component of the
cytoskeleton was similar in organization to the fine structure of
filamentous tubulin. It appears, however, that the filaments are less
well organized in parallel arrays than either the microtubules or the
microfilaments. Astrocytic processes were particularly detectable in
the U-251 cells by vimentin staining (Fig. 1C). We have previously
shown that these processes mediate cell-to-cell spread of MV in vitro
(13a). Once again no disassembly of this intermediate
filament was observed in MVeGFP-infected cells (Fig. 1C). Extended
filaments which were longer than those present in single cells were
visible in syncytia, again indicating that assembly is not noticeably
impaired within infected cells, as was also the case for actin and
tubulin. A number of viruses have been shown to cause alterations in
the intermediate-filament-based cytoskeletons (37, 46). RSV
infection of Hep-2 cells leads to morphological changes of vimentin and
an overall reduction in abundance, possibly due to proteolytic
degradation (21). CDV infection of epithelial cells has been
shown to lead to a disruption of the intermediate-filament network
(26).
Disruption of the cytoskeleton therefore seems to depend on the virus
studied. Here we clearly demonstrate that MV infection
does not perturb
the microfilament-, intermediate-filament-, or
microtubule-based
cytoskeletons of the two astrocytoma cell lines
even when
cell-pathogenic effect has progressed to form large,
but intact,
syncytia.
MVeGFP disrupts the GFAP-based cytoskeleton of astrocytoma
cells.
Glial-fibrillary-acidic protein (GFAP) is an intermediate
filament of the astrocytic cytoskeleton. This protein is found almost exclusively in astrocytes and is therefore commonly used as a marker
for these cells (33). Its initial expression marks the differentiation of precursor cells into astrocytes, and its
up-regulation accompanies the reactive response to CNS injury
(15). Due to the contribution of GFAP to the astrocyte
cytoskeleton, we examined the effects of MVeGFP infection on the
organization of this protein. Immunocytochemistry was carried out as
described above. GFAP was detected using a rabbit polyclonal antiserum
(Dako) at a dilution of 1:100 in PBS containing 0.5% Triton X-100.
CY3-conjugated sheep anti-rabbit immunoglobulin G (Sigma) was used as
the secondary antibody. Immunocytochemical detection of GFAP in
paraformaldehyde-fixed GCCM cells proved problematic (data not shown).
This was disappointing, as we wished to be consistent and continue to
examine the cytoskeleton in MVeGFP-infected cells using EGFP
autofluorescence as an indicator of infection. For this,
paraformaldehyde fixation was a prerequisite, as EGFP autofluorescence
is rapidly lost when all organic fixatives are used. Detection of GFAP
expression in the U-251 cells was more satisfactory. Nevertheless, it
was important to use the cells at a low passage number due to the
overall decrease in the levels of expression of GFAP as cells were
cultured. Not all U-251 cells stained equally for GFAP, and it proved
essential to carry out incubations in the presence of detergent to
improve the detection of the fibrillary network. However, greater than
99% of cells were GFAP positive, permitting a satisfactory examination
of the effects of MVeGFP infection on this intermediate filament in
these cells. Uninfected U-251 cells stain brightly for GFAP, and MVeGFP was observed to efficiently infect GFAP-positive cells and form syncytia (Fig. 2A). At this low
magnification large numbers of infected and uninfected cells are shown.
In the uninfected cells GFAP was present as a fibrillary network which
was similar in organization to that of vimentin. Astrocytic processes,
which connect the cells, also stained positive for GFAP. A severe
disruption of the GFAP cytoskeletal network was seen in MVeGFP-infected
cells, and the overall amount of GFAP staining was reduced compared to that of the uninfected cells. Intensity profiles were plotted, using
quantification software installed on the Leica TCS/NT confocal microscope, to assess the overall levels of fluorescence derived from
the presence of GFAP and EGFP. A line was drawn across the composite
data sets through a region of uninfected and infected cells. The
analysis software was used to determine the total intensity of red and
green in each pixel present along the length of this line, and the
results were obtained as graphs (Fig. 2C and D). A direct correlation
between infection (EGFP positive) and decrease in GFAP levels was
observed (Fig. 2C). The line from which this profile was obtained is
shown in red in Fig. 2A. This type of analysis was repeated for
complete data sets collected from 10 distinct syncytia present in
different areas of the infected monolayer. Similar profiles were
obtained in all cases. Duplicate coverslips, infected at the same time
with the same virus pool, were stained, as described above, for the
intermediate filament vimentin and are shown at the same magnification
for comparison (Fig. 2B). No disruption of the vimentin cytoskeleton
had been observed previously (Fig. 1C). Therefore, this
intermediate-filament protein served as the best control for this type
of analysis. In this case no decrease in the intensity of the vimentin
staining was observed in the infected area (Fig. 2D). Again, the line
chosen from which this profile was produced is shown in red in Fig. 2B.
Ten control data sets showed no diminution of the amount of vimentin in
infected cells. An extreme example of GFAP disruption is shown at a
higher magnification (Fig. 2E to G). In this case GFAP was barely
detectable within the main body of the syncytium. Positive staining was
observed within the syncytium, albeit at a very low level. This
residual GFAP seemed to aggregate around the nucleus. Cells on the
periphery of a syncytium can be assumed to be more recently infected
than those in the center. GFAP staining in these infected cells was diminished compared to that in the uninfected cells, and the
cytoskeletal network showed a certain degree of reorganization. This
seems, therefore, to represent an intermediate stage in the
disintegration of the GFAP cytoskeletal network. Association of
residual GFAP with the nucleus was also observed. Examination of the
GFAP fibrils demonstrated that they were much shorter than those in
uninfected cells. Therefore, a reorganization of the GFAP-based
cytoskeleton occurs in many of the infected astrocytoma cells upon
MVeGFP infection. This has not been previously reported for MV.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 2.
Effect of MVeGFP infection on the GFAP and vimentin
cytoskeleton. U-251 cells were infected, fixed, and examined by CSLM
for autofluorescence and immunoreactivity, as described for Fig. 1.
GFAP was visualized using a polyclonal antiserum and CY3-conjugated
secondary antibody (red). Vimentin was visualized using a monoclonal
antibody and a CY3-conjugated secondary antibody (red). EGFP
autofluorescence (green) indicates infected cells. (A) Disruption of
GFAP within MVeGFP-infected syncytia. Magnification, ×160. The red
line crossing the image indicates the region selected for
quantification of green and red fluorescence using the TCS/NT software.
(B) Lack of disruption of the vimentin cytoskeleton. The line used for
subsequent quantification is shown in red. Magnification, ×160. (C)
Intensity profile obtained from panel A showing a correlation between
the decrease in GFAP (red) and the increase in EGFP (green)
autofluorescence. (D) Intensity profile obtained from panel B showing
no alteration in vimentin (red) staining within areas of infection
(green). (E to G) Severe disruption of GFAP cytoskeleton in U-251
cells. (E) Infection of cells shown by EGFP autofluorescence. (F)
Vimentin staining. (G) Overlaid image. Magnification, ×400. Strongly
positive GFAP cells were readily observed (arrow c); these were not
present within the syncytia. In more recently infected cells at the
peripheries of the syncytia (arrow b), the intermediate-filament
network was partially disrupted and the overall amount of GFAP staining
was diminished. A residual amount of GFAP occasionally remained
associated with the nuclei of cells in the central areas of the
syncytia (arrow a).
|
|
The closely related
Morbillivirus CDV causes a demyelinating
disease (reviewed by Summers and Appel [
49]). CDV
primarily
infects astrocytes producing intracytoplasmic and
intranuclear
inclusion bodies (
40). A small percentage (5%)
of macrophages
are also thought to be infected in the acute
demyelinating lesions
(
38). Double
labeling-immunohistochemistry has been used to
detect viral antigen and
GFAP in astrocytes present in, or derived
from, brain tissues of
CDV-infected animals. In vitro-infected
primary cultures have also been
examined (
25,
54,
56). An
overall decrease has been
observed, both in vivo and in vitro,
in the numbers of GFAP-positive
cells, the prevalence of astrocytic
processes, and GFAP staining in
some cells (
53,
57). Neither
of these studies, however,
links this diminution in GFAP staining
with a reorganization of the
cytoskeleton. Infection of primary
fetal astrocytes with a lytic
varicella-zoster virus causes a
down-regulation or modification
of GFAP expression (
28). Morphological
changes in the
GFAP cytoskeleton which were very similar to those
observed for MV
infection were observed (Fig.
2), demonstrating
that an alteration of
the GFAP organization is not without precedent,
albeit, in the case of
varicella-zoster virus, in a lytic
virus.
In this study we set out to examine the effect of MV infection on the
cytoskeleton. MVeGFP was used to facilitate the examination
of the
cytoskeleton by CSLM because of its ability to express
EGFP, which
produces a diffuse cytoplasmic autofluorescence. We
observed no
disruption of the actin-, vimentin-, or tubulin-based
cytoskeletal
networks. A disruption of the GFAP cytoskeleton was
observed. A direct
correlation between MVeGFP infection and a
decrease in GFAP amount was
confirmed using quantitative confocal
fluorescence microscopy. This is
the first time that this effect
has been noted for a fusogenic virus.
Whether this disruption
is a passive or active phenomenon remains
unclear. It also remains
to be seen if this decrease in GFAP mirrors
the in vivo situation.
This is an in vitro study which has examined
effects in transformed
cell lines because they expressed appreciable
levels of GFAP.
Nevertheless, this finding is important as the effect
of MV on
GFAP may give rise to an underestimation of the numbers of
infected
astrocytes in MV infection of the
CNS.
 |
ACKNOWLEDGMENTS |
We are very grateful to Martin Billeter for advice and constructive
criticism throughout the course of this study. We acknowledge the help
of Uta Gassen in the critical reading of the manuscript. We thank Roy
Creighton for photographic work, Paula Haddock for excellent technical
assistance, and Aaron Maule for advice on phalloidin staining.
This work was supported by the Wellcome Trust (grant 047245).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: School of
Biology and Biochemistry, The Queen's University of Belfast, Medical
Biology Centre, 97 Lisburn Rd., Belfast BT9 7BL, Northern Ireland,
United Kingdom. Phone: 01232 272060. Fax: 01232 236505. E-mail:
p.duprex{at}qub.ac.uk.
 |
REFERENCES |
| 1.
|
Allen, I. V.,
S. McQuaid,
J. McMahon,
J. Kirk, and R. McConnell.
1996.
The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination.
J. Neuropathol. Exp. Neurol.
55:471-480[Medline].
|
| 2.
|
Bedows, E.,
K. M. Rao, and M. J. Welsh.
1983.
Fate of microfilaments in Vero cells infected with measles virus and herpes simplex virus type 1.
Mol. Cell. Biol.
3:712-719[Abstract/Free Full Text].
|
| 3.
|
Bigner, D. D.,
S. H. Bigner,
J. Ponten,
B. Westermark,
M. S. Mahaley,
E. Ruoslahti,
H. Herschman,
L. F. Eng, and C. J. Wikstrand.
1981.
Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.
J. Neuropathol. Exp. Neurol.
40:201-229[Medline].
|
| 4.
|
Bohn, W.,
G. Rutter,
H. Hohenberg,
K. Mannweiler, and P. Nobis.
1986.
Involvement of actin filaments in budding of measles virus: studies on cytoskeletons of infected cells.
Virology
149:91-106[CrossRef][Medline].
|
| 5.
|
Bohn, W.,
K. Mannweiler,
H. Hohenberg, and G. Rutter.
1987.
Replica-immunogold technique applied to studies on measles virus morphogenesis.
Scanning Microsc.
1:319-330[Medline].
|
| 6.
|
Bowden, D. S.,
J. S. Pedersen,
B. H. Toh, and E. G. Westaway.
1987.
Distribution by immunofluorescence of viral products and actin-containing cytoskeletal filaments in rubella virus-infected cells.
Arch. Virol.
92:211-219[CrossRef][Medline].
|
| 7.
|
Burke, E.,
L. Dupuy,
C. Wall, and S. Barik.
1998.
Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus.
Virology
252:137-148[CrossRef][Medline].
|
| 8.
|
Cathomen, T.,
H. Y. Naim, and R. Cattaneo.
1998.
Measles virus with altered envelope protein cytoplasmic tails gain cell fusion competence.
J. Virol.
72:1224-1234[Abstract/Free Full Text].
|
| 9.
|
Cattaneo, R., and J. K. Rose.
1993.
Cell fusion by the envelope glycoproteins of persistent measles viruses which cause lethal human brain disease.
J. Virol.
67:1493-1502[Abstract/Free Full Text].
|
| 10.
|
Ceccaldi, P. E.,
F. Valtorta,
S. Braud,
R. Hellio, and H. Tsiang.
1997.
Alteration of the actin-based cytoskeleton by rabies virus.
J. Gen. Virol.
78:2831-2835[Abstract].
|
| 11.
|
Chen, W. F.,
M. M. Soong,
S. C. Liang, and D. M. Wang.
1986.
Cytochalasin B changes the cytoskeletal organisation in Newcastle disease virus-infected cells.
Proc. Natl. Sci. Counc. Repub. China
10:137-144.
|
| 12.
|
Cudmore, S.,
I. Reckmann, and M. Way.
1997.
Viral manipulations of the actin cytoskeleton.
Trends Microbiol.
5:142-148[CrossRef][Medline].
|
| 13.
|
Dörig, R. E.,
A. Marcil,
A. Chopra, and C. D. Richardson.
1993.
The human CD46 is a receptor for measles virus (Edmonston strain).
Cell
75:295-305[CrossRef][Medline].
|
| 13a.
|
Duprex, W. P.,
S. McQuaid,
L. Hangartner,
M. A. Billeter, and B. K. Rima.
1999.
Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus.
J. Virol.
73:9568-9575[Abstract/Free Full Text].
|
| 14.
|
Ehrnst, A., and K. G. Sundqvist.
1976.
The mechanisms of appearance of viral glycoproteins at the cell surface membrane.
Exp. Cell Biol.
44:198-225[Medline].
|
| 15.
|
Eng, L. F., and R. S. Ghirnikar.
1994.
GFAP and astrogliosis.
Brain Pathol.
4:229-237[Medline].
|
| 16.
|
Fagraeus, A.,
D. L. Tyrrell,
R. Norberg, and E. Norrby.
1978.
Actin filaments in paramyxovirus-infected human fibroblasts studied by indirect immunofluorescence.
Arch. Virol.
57:291-296[CrossRef][Medline].
|
| 17.
|
Fagraeus, A.,
M. Bottiger,
L. Heller, and E. Norrby.
1981.
Replication of poliovirus and measles virus in cultures of human lymphoblastoid and of Burkitt lymphoma cell lines.
Arch. Virol.
69:229-237[CrossRef][Medline].
|
| 18.
|
Fischer, F.,
C. F. Stegen,
C. A. Koetzner, and P. S. Masters.
1998.
Construction of a mouse hepatitis virus recombinant expressing a foreign gene.
Adv. Exp. Med. Biol.
440:291-295[Medline].
|
| 19.
|
Foster, T. P.,
G. V. Rybachuk, and K. G. Kousoulas.
1998.
Expression of the enhanced green fluorescent protein by herpes simplex virus type 1 (HSV-1) as an in vitro or in vivo marker for virus entry and replication.
J. Virol. Methods
75:151-160[CrossRef][Medline].
|
| 20.
|
Furukawa, R., and M. Fechheimer.
1997.
The structure, function, and assembly of actin filament bundles.
Int. Rev. Cytol.
175:29-90[Medline].
|
| 21.
|
Garcia-Barreno, B.,
J. L. Jorcano,
T. Aukenbauer,
C. Lopez-Galindez, and J. A. Melero.
1998.
Participation of cytoskeletal intermediate filaments in the infectious cycle of human respiratory syncytial virus (RSV).
Virus Res.
9:307-321.
|
| 22.
|
Ghali, M., and J. Schneider-Schaulies.
1998.
Receptor (CD46)- and replication-mediated interleukin-6 induction by measles virus in human astrocytoma cells.
J. Neurovirol.
4:521-530[Medline].
|
| 23.
|
Griffin, J. A., and R. W. Compans.
1979.
Effect of Cytochalasin B on the maturation of enveloped viruses.
J. Exp. Med.
150:379-391[Abstract/Free Full Text].
|
| 24.
|
Gupta, S.,
B. P. De,
J. A. Drazba, and A. K. Banerjee.
1998.
Involvement of actin microfilaments in the replication of human parainfluenza virus type 3.
J. Virol.
72:2655-2662[Abstract/Free Full Text].
|
| 25.
|
Hamburger, D.,
C. Griot,
A. Zurbriggen,
C. Orvell, and M. Vandevelde.
1991.
Loss of virulence of canine distemper virus is associated with a structural change recognised by a monoclonal antibody.
Experientia
47:842-845[CrossRef][Medline].
|
| 25a.
|
Hangartner, L.
1997.
M.S. thesis.
University of Zurich, Zurich, Switzerland.
|
| 25b.
|
He, B.,
R. G. Paterson,
C. D. Ward, and R. A. Lamb.
1997.
Recovery of infectious SV5 from cloned DNA and expression at a foreign gene.
Virology
237:249-260[CrossRef][Medline].
|
| 26.
|
Howard, J. M.,
B. S. Eckert, and L. Y. Bourguignon.
1983.
Comparison of cytoskeletal organisation in canine distemper virus-infected and uninfected cells.
J. Gen. Virol.
64:2379-2385[Abstract/Free Full Text].
|
| 27.
|
Jabbour, J. T.,
D. A. Duenas,
J. L. Sever,
H. M. Krebs, and L. Horta-Barbosa.
1972.
Epidemiology of subacute sclerosing panencephalitis (SSPE). A report of the SSPE registry.
JAMA
220:959-962[Abstract/Free Full Text].
|
| 28.
|
Kennedy, P. G.,
E. O. Major,
R. K. Williams, and S. E. Straus.
1994.
Down-regulation of glial fibrillary acidic protein expression during acute lytic varicella-zoster virus infection of cultured human astrocytes.
Virology
205:558-562[CrossRef][Medline].
|
| 29.
|
Korn, E. D.
1982.
Acanthamoeba castellanii: methods and perspectives for study of cytoskeleton proteins.
Methods Cell Biol.
25:313-332.
|
| 30.
|
Liebert, U. G.
1997.
Measles virus infections of the central nervous system.
Intervirology
40:176-184[Medline].
|
| 31.
|
Liebert, U. G.,
K. Baczko,
H. Budka, and V. ter Meulen.
1986.
Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis.
J. Gen. Virol.
67:2435-2544[Abstract/Free Full Text].
|
| 32.
|
Mahalingam, R.,
M. Wellish,
T. White,
K. Soike,
R. Cohrs,
B. K. Kleinschmidt-DeMasters, and D. H. Gilden.
1998.
Infectious simian varicella virus expressing the green fluorescent protein.
J. Neurovirol.
4:438-440[Medline].
|
| 33.
|
McLendon, R. E., and D. D. Bigner.
1994.
Immunohistochemistry of the glial fibrillary acidic protein: basic and applied considerations.
Brain Pathol.
4:221-228[Medline].
|
| 34.
|
Mesquita, R.,
E. Castanos-Velez,
P. Biberfeld,
R. M. Troian, and M. M. de Siqueira.
1998.
Measles virus antigen in macrophage/microglial cells and astrocytes of subacute sclerosing panencephalitis.
APMIS
106:553-561[Medline].
|
| 35.
|
Moyer, S. A.,
S. C. Baker, and J. L. Lessard.
1986.
Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs.
Proc. Natl. Acad. Sci. USA
83:5405-5409[Abstract/Free Full Text].
|
| 36.
|
Moyer, S. A.,
S. C. Baker, and S. M. Horikami.
1990.
Host cell proteins required for measles virus reproduction.
J. Gen. Virol.
71:775-783[Abstract/Free Full Text].
|
| 37.
|
Murti, K., and R. Goorha.
1989.
Synthesis of frog virus 3 proteins occurs on intermediate filament-bound polyribosomes.
Biol. Cell
65:205-214[CrossRef][Medline].
|
| 38.
|
Mutinelli, F.,
M. Vandevelde,
C. Griot, and A. Richard.
1989.
Astrocytic infection in canine distemper virus-induced demyelination.
Acta Neuropathol.
77:333-335[CrossRef][Medline].
|
| 39.
|
Naniche, D.,
G. Varior-Krishnan,
F. Cervoni,
T. F. Wild,
B. Rossi,
C. Rabourdin-Combe, and D. Gerlier.
1993.
Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus.
J. Virol.
67:6025-6032[Abstract/Free Full Text].
|
| 40.
|
Pearce-Kelling, S.,
W. J. Mitchell,
B. A. Summers, and M. J. Appel.
1990.
Growth of canine distemper virus in cultured astrocytes: relationship to in vivo persistence and disease.
Microb. Pathog.
8:71-82[CrossRef][Medline].
|
| 41.
|
Peebles, M. E.
1991.
Paramyxovirus M proteins. Pulling it all together and taking it on the road, p. 247-256.
In
D. W. Kingsbury (ed.), The paramyxoviruses. Plenum Press, New York, N.Y.
|
| 42.
|
Radecke, F.,
P. Spielhofer,
H. Schneider,
K. Kaelin,
M. Huber,
C. Dotsch,
G. Christiansen, and M. A. Billeter.
1995.
Rescue of measles virus from cloned DNA.
EMBO J.
14:5773-5784[Medline].
|
| 43.
|
Rubino, S.,
A. Monaco,
A. Degener, and P. Cappuccinelli.
1991.
Cell microfilaments disorganisation is an early cytopathic effect in mengo virus replication.
Microbiologica
14:95-102[CrossRef][Medline].
|
| 44.
|
Rutter, G., and K. Mannweiler.
1977.
Alterations of actin-containing structures in BHK21 cells infected with Newcastle disease virus and vesicular stomatitis virus.
J. Gen. Virol.
37:233-242[Abstract/Free Full Text].
|
| 45.
|
Schneider-Schaulies, J.,
S. Schneider-Schaulies, and V. ter Meulen.
1993.
Differential induction of cytokines by primary and persistent measles virus infections in human glial cells.
Virology
195:219-228[CrossRef][Medline].
|
| 46.
|
Sharpe, A. H.,
L. B. Chen, and B. N. Fields.
1982.
The interaction of mammalian reoviruses with the cytoskeleton of monkey kidney CV-1 cells.
Virology
120:399-411[CrossRef][Medline].
|
| 47.
|
Simon, K. O.,
P. A. Whitaker-Dowling,
J. S. Youngner, and C. C. Widnell.
1990.
Sequential disassembly of the cytoskeleton in BHK21 cells infected with vesicular stomatitis virus.
Virology
177:289-297[CrossRef][Medline].
|
| 48.
|
Stallcup, K. C.,
C. S. Raine, and B. N. Fields.
1983.
Cytochalasin B inhibits the maturation of measles virus.
Virology
124:59-74[CrossRef][Medline].
|
| 49.
|
Summers, B. A., and M. J. Appel.
1994.
Aspects of canine distemper virus and measles virus encephalomyelitis.
Neuropathol. Appl. Neurobiol.
20:525-534[Medline].
|
| 50.
|
Tashiro, M.,
J. T. Seto,
H. D. Klenk, and R. Rott.
1993.
Possible involvement of microtubule disruption in bipolar budding of a Sendai virus mutant, F1-R, in epithelial MDCK cells.
J. Virol.
67:5902-5910[Abstract/Free Full Text].
|
| 51.
|
Tyrrell, D. L., and A. Ehrnst.
1979.
Transmembrane communication in cells chronically infected with measles virus.
J. Cell Biol.
81:396-402[Abstract/Free Full Text].
|
| 52.
|
Ulloa, L.,
R. Serra,
A. Asenjo, and N. Villanueva.
1998.
Interactions between cellular actin and human respiratory syncytial virus (HRSV).
Virus Res.
53:13-25[CrossRef][Medline].
|
| 53.
|
Vandevelde, M.,
P. Bichsel,
S. Cerruti-Sola,
A. Steck,
F. Kristensen, and R. J. Higgins.
1983.
Glial proteins in canine distemper virus-induced demyelination. A sequential immunocytochemical study.
Acta Neuropathol.
59:269-226[CrossRef][Medline].
|
| 54.
|
Vandevelde, M.,
A. Zurbriggen,
R. J. Higgins, and D. Palmer.
1985.
Spread and distribution of viral antigen in nervous canine distemper.
Acta Neuropathol.
67:211-218[CrossRef][Medline].
|
| 55.
|
Wild, T. F., and R. Buckland.
1995.
Functional aspects of envelope-associated measles virus proteins, p. 51-64.
In
V. ter Meulen, and M. A. Billeter (ed.), Measles virus. Springer-Verlag KG, Berlin, Germany.
|
| 56.
|
Zurbriggen, A.,
M. Vandevelde, and M. Dumas.
1986.
Secondary degeneration of oligodendrocytes in canine distemper virus infection in vitro.
Lab. Investig.
54:424-431[Medline].
|
| 57.
|
Zurbriggen, A., and M. Vandevelde.
1983.
Canine distemper virus-induced glial cell changes in vitro.
Acta Neuropathol.
62:51-58[CrossRef][Medline].
|
Journal of Virology, April 2000, p. 3874-3880, Vol. 74, No. 8
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.